leadf
logo-loader
NASDAQ:ZYNE

Zynerba Pharmaceuticals

Receive alerts
Market:
NASDAQ
Market Cap:
$133.95 m
Price
4.55 USD
Change
9.38%
52 weeks high
7.44
52 weeks low
2.55

In brief

At Zynerba Pharmaceuticals, our team is dedicated to developing next-generation transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. Often, these diseases have few, if any, treatment options and can leave patients and their families feeling helpless and alone. Zynerba is committed to developing breakthrough therapies to transform the quality of lives of patients and their families as they battle these conditions.

Snapshot

All eyes are on Zynerba's meeting with the FDA in the fourth quarter of 2020 to discuss pivotal CONNECT-FX data and the regulatory path for potential approval